>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

HHS Releases Omnibus HIPAA Rule

Wednesday, January 23, 2013

The Department of Health and Human Services (HHS) recently released the omnibus Health Insurance Portability and Accountability Act (HIPAA) final rule.  In a press release, HHS cited enhancing patient privacy protections and patient rights to their health information as the primary reasons for the omnibus rule. 

ASA is currently analyzing the entire 563 page rule.  Some areas of preliminary interest include:

  • Adoption of a default presumption that an impermissible use or disclosure is a data breach unless it can be determined through a risk assessment that there is a low probability that data may be compromised (under HITECH breach notification requirements).
  • Implementation of the HIPAA language related to the expansion of privacy & security obligations to business associates. 
  • Strengthens the government’s enforcement authority.
  • Requires updates to the notice of privacy practices. 

« Back to Washington Alerts